| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 03/18/1993 | CA2305767A1 Steroid sulphatase inhibitors |
| 03/18/1993 | CA2305758A1 Steroid sulphatase inhibitors |
| 03/18/1993 | CA2305749A1 Steroid sulphatase inhibitors |
| 03/10/1993 | CN1069734A Synthetic method of 11,19-cyclopolymerized pregnenone analogue |
| 03/09/1993 | US5192754 Treatment with steroids |
| 03/04/1993 | WO1993003732A1 Gaba receptor modulators |
| 03/04/1993 | DE4129005A1 Verfahren zur herstellung von 14(alpha)-hydroxy-4-androsten-3,17-dion Process for the preparation of 14 (alpha) -hydroxy-4-androstene-3,17-dione |
| 03/03/1993 | CN1019978C 11-aryioestrane and 11-arylpregnalle derivatives and preparing method thereof |
| 02/24/1993 | EP0527962A1 Method, compositions, and compounds for modulating brain excitability |
| 02/16/1993 | CA1313653C 7-substituted 19-nor steroids; process for preparing them; their use as drugs and pharmaceutical compositions containing them |
| 02/16/1993 | CA1313622C Pharmaceutical composition containing 17.beta.oestradiol and desogestr el |
| 02/10/1993 | EP0526849A1 Novel substituted N-Fluoropyridiniumsulfonate, intermediates therefor and preparation processes thereof |
| 02/10/1993 | EP0374185B1 IMPROVED 9$g(a)-DEHALOGENATION PROCESS |
| 02/02/1993 | CA2074991A1 Novel substituted n-fluoropyridiniumsulfonate, intermediates therefor and preparation processes thereof |
| 01/27/1993 | EP0524813A1 Selective thioketalization process, process for preparing thioenol ethers from thioketals, and process for the preparation of thioketals |
| 01/26/1993 | US5182381 Intermediates for 3-keto-19-nor-Δ4,9 -steroids |
| 01/26/1993 | CA2074430A1 Selective thioketalization process, process for preparing thioenol ethers from thioketals, and process for the preparation of thioketals |
| 01/20/1993 | EP0523132A1 PROCESS FOR 9$g(a)-HYDROXY STEROID DEHYDRATION |
| 12/22/1992 | CA1311749C 17.alpha.-(ARYLOXY OR ALKOXY) ANDROSTENES |
| 12/08/1992 | US5169966 Process for producing an α-acyloxy-α, β-unsaturated carbonyl compound and a 20-acyloxy-17(20)-methylen-21-al-steroid compound |
| 12/02/1992 | EP0516530A1 New 6-substituted steroids with a thioethyl group in the 10 position, a process for their preparation and intermediates therefor, their use as medicines and pharmaceutical compositions thereof |
| 12/02/1992 | EP0515386A1 Glycoalkaloids |
| 12/01/1992 | USRE34136 9 alpha, 11 beta-substituted and 11 beta-substituted estranes |
| 12/01/1992 | CA1310957C 10.beta.-ALKYNYLESTRENE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
| 11/28/1992 | CA2069570A1 6-substituted steroid products containing a thioethyl group in position 10; process for preparing the same and intermediate compounds thereof; their use as therapeutic agents and pharmaceutical products containing them |
| 11/24/1992 | US5166201 2β,19-ethylene bridged steroids as aromatase inhibitors |
| 11/24/1992 | US5166200 Administering 14a-hydroxy-4-androstene-3,6,17-trione or ester derivative |
| 11/24/1992 | US5166146 Amino acid cyclopentanophenonthrene compounds |
| 11/24/1992 | US5166055 Microbiological preparation of 9-alpha-hydroxy-17-keto steroids |
| 11/24/1992 | CA1310631C 17.alpha.-HALOGEN-VINYLE-STRANES |
| 11/24/1992 | CA1310630C 11.beta.-PHENYL-GONANES, THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
| 11/18/1992 | CN1066271A 14 beta-h-,14-and 15-ene-11 beta-aryl-4-estrene |
| 10/28/1992 | EP0510167A1 Novel steroidal organic substance crystallization method and compounds thereby obtained. |
| 10/27/1992 | CA1309400C 6- or 7-methylenandrosta-1,4-diene-3,17-dione derivatives and process for their preparation |
| 10/20/1992 | US5157031 Method for prophylaxis of obesity |
| 10/20/1992 | CA1309088C 17.beta.-(CYCLOPROPYLOXY)ANDROST-5-EN-3.beta.-OL AND RELATED COMPOUNDS USEFUL ASC -- -LYASE INHIBITORS |
| 10/07/1992 | CN1065070A 6,7-modified 11beta-aryl-4-estrene |
| 09/30/1992 | EP0506565A1 Use of 4,9,11-trienic steroids in compositions for turkeys |
| 09/29/1992 | US5151533 Process for the production of 3-hydroxy-1,3,5(10)-estratrien-17-one |
| 09/29/1992 | CA2064358A1 Use of 4, 9, 11-trienic steroids in compositions for administration to turkeys |
| 09/29/1992 | CA1308095C 11.beta.-ARYLESTRADINENES, THE PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME |
| 09/22/1992 | US5149696 Antiestrogens |
| 09/09/1992 | EP0502595A2 Amide chelates, their metal complexes and their use in diagnosis and therapy |
| 09/08/1992 | US5145847 Antiestrogens |
| 09/08/1992 | CA2062454A1 Amide-chelates, their metal complexes as well as their use in diagnosis and treatment |
| 09/02/1992 | CN1064078A Steroid esters |
| 09/01/1992 | US5144017 Steroids |
| 09/01/1992 | CA1306993C PROCESS FOR THE PRODUCTION OF 17.alpha.-ETHINYL-17.beta.-HYDROXY-18-METHYL-4,15-ESTRADIEN-3-ONE AND NEW INTERMEDIATE PRODUCTS FOR THIS PROCESS |
| 09/01/1992 | CA1306950C Buccal administration of estrogens |
| 08/27/1992 | WO1992014474A1 Methods for the treatment of osteoporosis |
| 08/25/1992 | CA1306743C DOUBLE ESTER OF 16.beta.-ETHYLESTRAN-17.beta.-OL DERIVATIVES |
| 08/20/1992 | WO1992013873A1 Novel steroid esters |
| 08/20/1992 | CA2100453A1 Novel steroid esters |
| 08/11/1992 | US5137882 Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors |
| 08/06/1992 | WO1992012983A1 A method of fluorinating by using n-fluoropyridinium pyridine heptafluorodiborate |
| 07/30/1992 | DE4102948A1 New 2; and 4-fluoro:methyl-androsta:diene-di:one - useful as aromatase inhibitors prevent oestrogen biosynthesis and oestrogen dependent diseases |
| 07/29/1992 | EP0496520A1 Novel bone acting agents |
| 07/29/1992 | EP0495825A1 Use of antigestagens in the manufacture of medicaments. |
| 07/29/1992 | EP0300062B1 Novel androst-4-ene-3,17-dione derivatives and process for their preparation |
| 07/29/1992 | CN1063107A Preparation of 1,3,5 (10), 9 (11)-female steroid tetraethenyl from 1,3,5 (10), 8-female steroid tetraethylene |
| 07/28/1992 | US5134135 Antiandrogenic sulfonylsteroidooxazoles |
| 07/28/1992 | CA1305699C 17-substituted androsta-1,4-dien-3-one derivatives |
| 07/23/1992 | CA2059421A1 Bone acting agents |
| 07/21/1992 | US5132299 Antigestagenic, antiglucocorticoid |
| 07/08/1992 | CN1062464A Contraceptive regimen |
| 07/01/1992 | CN1062290A Low estrogen oral contraceptives |
| 06/25/1992 | DE4042007A1 6,7-modifizierte-11(beta)-aryl-4-estrene 6,7-modified-11 (beta) -Aryl-4-Estrenes |
| 06/25/1992 | DE4042005A1 D-homo-(16-en)-11(beta)-aryl-4-estrene D-homo (16-s) -11 (beta) aryl-4-Estrenes |
| 06/25/1992 | DE4042004A1 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene 14 (beta) -h, 14 u. 15-en-11 (beta) aryl-4-Estrenes |
| 06/24/1992 | EP0491438A1 Contraceptive regimen |
| 06/24/1992 | EP0491415A1 Low estrogen oral contraceptives |
| 06/23/1992 | WO1992011279A1 D-HOMO-(16-EN)-11β-ARYL-4-ESTRENES, PROCESS FOR PRODUCING THEM AND THEIR USE AS MEDICAMENTS |
| 06/23/1992 | WO1992011278A1 14β-H-, 14- AND 15-EN-11β-aryl-4-ESTRENES |
| 06/23/1992 | WO1992011277A1 6,7-MODIFIED 11β-ARYL-4-ESTRENES |
| 06/23/1992 | CA2099018A1 6,7-modified 11.beta.-aryl-4-estrenes |
| 06/23/1992 | CA2099016A1 14.beta.-h-, 14- and 15-en-11.beta.-aryl-4-estrenes |
| 06/17/1992 | EP0218647B1 Skin treatment agents |
| 06/17/1992 | CN1061974A 2beta, 19-ethylene bridged steroids as aromatase inhibitors |
| 06/10/1992 | CN1061781A High-efficiency selective hydrolysis process |
| 06/09/1992 | US5120723 Alleviate stress, anxiety, seizures |
| 06/09/1992 | CA1302923C Process for producing 4-androstene -3,17-dione and 1,4-androstardiene -3,17-dione |
| 06/03/1992 | EP0488383A1 2-beta,19-ethylene bridged steroids as aromatase inhibitors |
| 05/29/1992 | WO1992008730A1 Novel steroidal organic substance crystallization method and compounds thereby obtained |
| 05/26/1992 | US5116994 Modified sytrene-divinylbenzene polymer |
| 05/26/1992 | US5116865 15,16-seco-19-nor progestins |
| 05/20/1992 | EP0485392A1 Androgen derivatives for use in the inhibition of sex steroid activity |
| 05/12/1992 | US5112815 9α-hydroxy-3-oxo-4,24(25)-stigmastadien-26-oic acid derivatives, a process for preparing same and pharmaceutical compositions containing same |
| 05/12/1992 | CA1300601C Estrane and androstane derivatives, process for producing them and preparations containing these compounds |
| 04/28/1992 | US5108996 Antiinflammatory agents |
| 04/22/1992 | EP0480950A1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 04/21/1992 | CA1299169C Steroids having a spiro cycle in position 17, their process and intermediaries,their use as medications and the pharmaceutical preparations containing such |
| 04/05/1992 | WO1992005763A1 Composition containing steroid derivatives |
| 04/05/1992 | CA2093349A1 Composition containing steroid derivatives |
| 04/02/1992 | WO1992005447A1 FUNCTIONAL ANTAGONISM BETWEEN PROTO-ONCOPROTEIN c-JUN AND HORMONE RECEPTORS |
| 04/02/1992 | CA2090407A1 Functional antagonism between proto-oncoprotein c-jun and hormone receptors |
| 03/24/1992 | US5098535 Process for preparing 14-α-hydroxy-4-androstene-3,6,17-trione |
| 03/19/1992 | WO1992004309A1 Novel 15,16-seco-19-nor progestins |
| 03/19/1992 | WO1992003925A1 Treatment process for promoting weight loss employing a substituted δ5-androstene |
| 03/19/1992 | CA2090759A1 Treatment process for promoting weight loss employing a substituted 5-androstene |
| 03/19/1992 | CA2071917A1 15,16-seco-19-nor progestins |